These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 32533570)

  • 1. Systematic review of the emerging literature on the effectiveness of naloxone access laws in the United States.
    Smart R; Pardo B; Davis CS
    Addiction; 2021 Jan; 116(1):6-17. PubMed ID: 32533570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between State Laws Facilitating Pharmacy Distribution of Naloxone and Risk of Fatal Overdose.
    Abouk R; Pacula RL; Powell D
    JAMA Intern Med; 2019 Jun; 179(6):805-811. PubMed ID: 31058922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional and temporal effects of naloxone access laws on opioid overdose mortality.
    Cataife G; Dong J; Davis CS
    Subst Abus; 2021; 42(3):329-338. PubMed ID: 31951788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.
    Lee B; Zhao W; Yang KC; Ahn YY; Perry BL
    JAMA Netw Open; 2021 Feb; 4(2):e2036687. PubMed ID: 33576816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Legal changes to increase access to naloxone for opioid overdose reversal in the United States.
    Davis CS; Carr D
    Drug Alcohol Depend; 2015 Dec; 157():112-20. PubMed ID: 26507172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid-overdose laws association with opioid use and overdose mortality.
    McClellan C; Lambdin BH; Ali MM; Mutter R; Davis CS; Wheeler E; Pemberton M; Kral AH
    Addict Behav; 2018 Nov; 86():90-95. PubMed ID: 29610001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Naloxone Access Laws on Fatal Synthetic Opioid Overdose Fatality Rates.
    Tabatabai M; Cooper RL; Wilus DM; Edgerton RD; Ramesh A; MacMaster SA; Patel PN; Singh KP
    J Prim Care Community Health; 2023; 14():21501319221147246. PubMed ID: 36625264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expert views on state-level naloxone access laws: a qualitative analysis of an online modified-Delphi process.
    Grant S; Smart R
    Harm Reduct J; 2022 Jun; 19(1):64. PubMed ID: 35676719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Legal requirements and recommendations to prescribe naloxone.
    Haffajee RL; Cherney S; Smart R
    Drug Alcohol Depend; 2020 Apr; 209():107896. PubMed ID: 32058248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of US states' adoption of naloxone access laws, 2001-2017.
    Bohler RM; Hodgkin D; Kreiner PW; Green TC
    Drug Alcohol Depend; 2021 Aug; 225():108772. PubMed ID: 34052687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: a modelling study.
    Irvine MA; Oller D; Boggis J; Bishop B; Coombs D; Wheeler E; Doe-Simkins M; Walley AY; Marshall BDL; Bratberg J; Green TC
    Lancet Public Health; 2022 Mar; 7(3):e210-e218. PubMed ID: 35151372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of untargeted naloxone distribution on opioid overdose outcomes.
    Dowd WN
    Health Econ; 2023 Dec; 32(12):2801-2818. PubMed ID: 37670413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Naloxone Coprescription Laws With Naloxone Prescription Dispensing in the United States.
    Sohn M; Talbert JC; Huang Z; Lofwall MR; Freeman PR
    JAMA Netw Open; 2019 Jun; 2(6):e196215. PubMed ID: 31225895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rates and Costs of Dispensing Naloxone to Patients at High Risk for Opioid Overdose in the United States, 2014-2018.
    Barenie RE; Gagne JJ; Kesselheim AS; Pawar A; Tong A; Luo J; Bateman BT
    Drug Saf; 2020 Jul; 43(7):669-675. PubMed ID: 32180134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a publicly funded pharmacy-dispensed naloxone program on fatal opioid overdose rates: A population-based study.
    Antoniou T; Men S; Tadrous M; Leece P; Munro C; Gomes T
    Drug Alcohol Depend; 2022 Jul; 236():109473. PubMed ID: 35523113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fentanyl harm reduction strategies among Latinx communities in the United States: a scoping review.
    Luna G; Dermid G; Unger JB
    Harm Reduct J; 2024 Aug; 21(1):150. PubMed ID: 39152433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naloxone laws facilitate the establishment of overdose education and naloxone distribution programs in the United States.
    Lambdin BH; Davis CS; Wheeler E; Tueller S; Kral AH
    Drug Alcohol Depend; 2018 Jul; 188():370-376. PubMed ID: 29776688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between naloxone prescribing and opioid overdose among patients with acute and chronic pain conditions.
    Qeadan F; Madden EF
    Addiction; 2022 Feb; 117(2):457-471. PubMed ID: 34286895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional variation in states' naloxone accessibility laws in association with opioid overdose death rates-Observational study (STROBE compliant).
    You HS; Ha J; Kang CY; Kim L; Kim J; Shen JJ; Park SM; Chun SY; Hwang J; Yamashita T; Lee SW; Dounis G; Lee YJ; Han DH; Byun D; Yoo JW; Kang HT
    Medicine (Baltimore); 2020 May; 99(22):e20033. PubMed ID: 32481373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naloxone and Buprenorphine Prescribing Following US Emergency Department Visits for Suspected Opioid Overdose: August 2019 to April 2021.
    Chua KP; Dahlem CHY; Nguyen TD; Brummett CM; Conti RM; Bohnert AS; Dora-Laskey AD; Kocher KE
    Ann Emerg Med; 2022 Mar; 79(3):225-236. PubMed ID: 34802772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.